| The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35, 1271-1285, 2017 | 167 | 2017 |
| Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria L Gulácsi, AM Rotar, M Niewada, O Löblová, F Rencz, G Petrova, I Boncz, ... The European journal of health economics 15, 13-25, 2014 | 119 | 2014 |
| Patients’ perceptions of information and education for renal replacement therapy: an independent survey by the European kidney Patients' Federation on information and support … W Van Biesen, SN van der Veer, M Murphey, O Loblova, S Davies PLoS One 9 (7), e103914, 2014 | 92 | 2014 |
| When epistemic communities fail: exploring the mechanism of policy influence O Löblová Policy studies journal 46 (1), 160-189, 2018 | 76 | 2018 |
| Centralizing and decentralizing governance in the COVID-19 pandemic: The politics of credit and blame SL Greer, S Rozenblum, M Falkenbach, O Löblová, H Jarman, N Williams, ... Health Policy 126 (5), 408-417, 2022 | 68 | 2022 |
| European integration in the era of permissive dissensus: Neofunctionalism and agenda-setting in European health technology assessment and communicable disease control SL Greer, O Löblová Comparative European Politics 15, 394-413, 2017 | 51 | 2017 |
| Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe O Löblová Health Economics, Policy and Law 11 (3), 253-273, 2016 | 44 | 2016 |
| Epistemic communities and experts in health policy-making O Löblová European journal of public health 28 (suppl_3), 7-10, 2018 | 37 | 2018 |
| Rationalizing the introduction and use of pharmaceutical products: The role of managed entry agreements in Central and Eastern European countries AM Rotar, A Preda, O Löblová, V Benkovic, S Zawodnik, L Gulacsi, ... Health Policy 122 (3), 230-236, 2018 | 33 | 2018 |
| Half a century of Wilson & Jungner: reflections on the governance of population screening S Sturdy, F Miller, S Hogarth, N Armstrong, P Chakraborty, C Cressman, ... Wellcome Open Research 5, 2020 | 32 | 2020 |
| When health technology assessment is confidential and experts have no power: the case of Hungary M Csanádi, O Löblová, P Ozierański, A Harsányi, Z Kaló, M McKee, ... Health Economics, Policy and Law 14 (2), 162-181, 2019 | 32 | 2019 |
| COVID-19 in Central and Eastern Europe: Focus on Czechia, Hungary, and Bulgaria O Löblová, J Rone, E Borbáth Coronavirus Politics: The Comparative Politics and Policy of COVID-19, 2021 | 27 | 2021 |
| The emerging social science literature on health technology assessment: a narrative review O Löblová, T Trayanov, M Csanádi, P Ozierański Value in Health 23 (1), 3-9, 2020 | 27 | 2020 |
| What has health technology assessment ever done for us? O Löblová Journal of health services research & policy 23 (2), 134-136, 2018 | 24 | 2018 |
| Who’s afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic O Löblová Health Economics, Policy and Law 13 (2), 137-161, 2018 | 18 | 2018 |
| Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology O Löblová, M Csanádi, P Ozierański, Z Kaló, L King, M McKee Health Policy 123 (7), 630-634, 2019 | 16 | 2019 |
| Transparency in practice: evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015 P Ozierański, O Löblová, N Nicholls, M Csanádi, Z Kaló, M McKee, L King Health Economics, Policy and Law 14 (2), 182-204, 2019 | 16 | 2019 |
| Patterns of alternative access: Unpacking the Slovak extraordinary drug reimbursement regime 2012-2016 O Löblová, M Csanádi, P Ozierański, Z Kaló, L King, M McKee Health Policy 123 (8), 713-720, 2019 | 15 | 2019 |
| Is the Polish ‘Law and Justice’(PiS) a Typical Populist Radical Right Party? A Health Policy Perspective M Zabdyr-Jamróz, O Löblová, AD Moise, I Kowalska-Bobko The Populist Radical Right and Health: National Policies and Global Trends …, 2021 | 10 | 2021 |
| The impact of the recession on health care expenditure — How does the Czech Republic, Hungary, Poland and Slovakia compare to other OECD countries? LG Baji, Petra, Márta Péntek, Imre Boncz, Valentin Brodszky, Olga Loblova ... Society and Economy 31 (1), 73-88, 2015 | 10* | 2015 |
Piotr OzieranskiReader in Sociology, Department of Social and Policy Sciences, University of BathDirección de correo verificada de bath.ac.uk
